It didn’t take long for the Justice Department to use the Supreme Court’s June 13 decision on the abortion pill mifepristone to bolster its appeal of a lower court ruling in a case dealing with the Affordable Care Act.
The high court’s unanimous decision in FDA v. Alliance for Hippocratic Medicine “reinforces the traditional limits on the Judicial power and confirms that the district court’s universal relief—vacating and enjoining required health care coverage for hundreds of millions of Americans who are not parties here— was erroneous,” DOJ attorney Daniel Aguilar said in a filing with the US Court of Appeals ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.